← Leaderboards
Hannah Meiselman
Pro Therapeutics Llc
$612,292
Attributed
$1,836,877
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $943.3K · FY2023–24$1M$750K$500K$250K$0
'23
'24
Funding mix
By agency
NIH$1,836,877 · 1
By mechanism
R44$1,836,877 · 1
Top collaborators
- Thomas Bollenbach2 shared
- Lisa M Larkin2 shared
Others in their field
Other Rising Stars on “Allogenic”
- Guang-Shing Cheng · Fred Hutchinson Cancer Center$3,067,611
- Kellie Bickel · Twinstrand Biosciences, Inc.$2,555,383
- Hunter Ramsdell Gibbons · Luminary Therapeutics, Inc.$1,962,052
- Riccardo Gottardi · Children'S Hosp Of Philadelphia$1,873,073
- Sayan Dasgupta · University Of Washington$1,836,282
- Saad J. Kenderian · Mayo Clinic Rochester$1,822,469
Research focus
AllogenicAnimalsAnterior Cruciate Ligament InjuryArthritisBiologicalBiological DevelopmentBiomaterial CompatibilityBiomechanicsBoneBone Marrow Mesenchymal Stem CellCapitalCell BankCellsCharacteristicsCicatrixClinicClinical TrialsCollagenCommercializationCommunitiesCostDesignDevicesAging Population